Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PFE

Pfizer

$43.45

-1.105 (-2.48%)

12:14
12/14/18
12/14
12:14
12/14/18
12:14
Hot Stocks
Pfizer announces new $10B share repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.52

-1.03 (-2.31%)

12:13
12/14/18
12/14
12:13
12/14/18
12:13
Hot Stocks
Pfizer raises quarterly dividend 6% to 36c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.52

-1.03 (-2.31%)

12:12
12/14/18
12/14
12:12
12/14/18
12:12
Hot Stocks
Breaking Hot Stocks news story on Pfizer »

Pfizer boosts dividend to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.87

-0.68 (-1.53%)

10:32
12/14/18
12/14
10:32
12/14/18
10:32
Hot Stocks
Pfizer receives positive CHMP opinion for oncology biosimilar ZIRABEV »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$44.55

0.38 (0.86%)

08:04
12/14/18
12/14
08:04
12/14/18
08:04
Hot Stocks
Pfizer initiates Phase 3 program for 20-Valent pneumococcal conjugate vaccine »

Pfizer announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

BMY

Bristol-Myers

$53.65

0.18 (0.34%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/14/18
12/14
04:55
12/14/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$53.65

0.18 (0.34%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$69.75

-1.15 (-1.62%)

MRK

Merck

$78.99

0.95 (1.22%)

PFE

Pfizer

$44.55

0.38 (0.86%)

FLDM

Fluidigm

$8.18

0.55 (7.21%)

NEO

NeoGenomics

$13.43

0.18 (1.36%)

SGEN

Seattle Genetics

$60.96

-0.92 (-1.49%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.79

0.24 (4.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

  • 12

    Dec

  • 12

    Dec

Thursday
ABBV

AbbVie

$87.49

-1.13 (-1.28%)

13:00
12/13/18
12/13
13:00
12/13/18
13:00
Hot Stocks
AbbVie announces $5B boost to stock repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$44.17

0.15 (0.34%)

09:39
12/13/18
12/13
09:39
12/13/18
09:39
Conference/Events
Pfizer management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 18

    Dec

BMY

Bristol-Myers

$53.47

1.03 (1.96%)

, RHHBY

Roche

$0.00

(0.00%)

08:40
12/13/18
12/13
08:40
12/13/18
08:40
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$53.47

1.03 (1.96%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$70.90

1.4 (2.01%)

MRK

Merck

$78.04

0.92 (1.19%)

PFE

Pfizer

$44.17

0.15 (0.34%)

FLDM

Fluidigm

$7.63

0.05 (0.66%)

NEO

NeoGenomics

$13.25

-0.62 (-4.47%)

SGEN

Seattle Genetics

$61.88

0.94 (1.54%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.55

-0.05 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

  • 12

    Dec

  • 12

    Dec

GLPG

Galapagos NV

$106.90

4.5 (4.39%)

, ABBV

AbbVie

$88.62

0.45 (0.51%)

08:14
12/13/18
12/13
08:14
12/13/18
08:14
Upgrade
Galapagos NV, AbbVie rating change  »

Galapagos NV upgraded to…

GLPG

Galapagos NV

$106.90

4.5 (4.39%)

ABBV

AbbVie

$88.62

0.45 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.